Video Transcript

Richard Reznick, Ph.D.
Research Analyst
Global Equity Team

Hi, everyone. I’m standing here in snowy Korea. We’re at a science park outside of Seoul. I’m about to get started on a busy day’s worth of meetings with Korean healthcare companies. Time to get started.

The healthcare industry in Korea is highly innovative, and one of the key takeaways from my visit was the medical aesthetic industry there is thriving.

Korea has the most plastic surgeons per capita in the world and performs more medical aesthetic procedures than anywhere else as well, which provides opportunity for the domestic companies in the industry.


The views and opinions expressed herein are those of the speaker(s) as of the date of publication, are subject to change without notice as economic and market conditions dictate, and may not reflect the views and opinions of other investment teams within William Blair. Factual information has been obtained from sources we believe to be reliable, but its accuracy, completeness, or interpretation cannot be guaranteed. This material may include estimates, outlooks, projections, and other forward-looking statements. Due to a variety of factors, actual events may differ significantly from those presented. This video has been provided for informational purposes only and should not be considered as investment advice or a recommendation of any particular strategy or investment product, or as an offer to buy or sell any securities or related financial instruments in any jurisdiction. Investment advice and recommendations can be provided only after careful consideration of an investor’s objectives, guidelines, and restrictions. Investing involves risks, including the possible loss of principal. Past performance is not indicative of future results.